Literature DB >> 29497919

VEGF-A regulates sFlt-1 production in trophoblasts through both Flt-1 and KDR receptors.

Zhonglin Xiao1,2, Songjun Li3, Yan Yu4, Mengxia Li1, Jie Chen1, Feng Wang3, Jian Zhang1, Weifen Deng5, Qing Yang6, Xiujun Fan7.   

Abstract

Studies have shown that sFlt-1 overproduction stimulated by excess VEGF of deciduous origin in trophoblasts can cause preeclampsia. However, the mechanism underlying how VEGF regulates sFtl-1 expression in trophoblasts remains unknown. To address this issue, JEG3 and HTR-8/SV neo (HTR8) trophoblast cell lines were used to investigate the signaling pathways involved in the regulation of sFlt-1 production via VEGF overexpression in vitro. JEG3 (VEGF-GFP-JEG3, V-J) and HTR8 (VEGF-GFP-HTR8, V-H) cells overexpressing VEGF165 were established by infecting the JEG3 and HTR8 cell lines with lentivirus expressing VEGF165. Both the mRNA and protein levels of VEGF and sFlt-1 were dramatically up-regulated in the V-J and V-H cells compared to the JEG3 and HTR8 cells, and they were significantly decreased after treatment with an Flt-1 receptor inhibitor (MK-2461), a KDR receptor inhibitor (XL-184), or an Flt-1 and KDR receptor inhibitor (ABT-869). The mRNA levels of sFlt-1, Flt-1, and KDR were increased in V-H cells after treatment, and the VEGF-A mRNA levels were also elevated. The migration and invasion abilities of JEG3 and HTR8 cells were decreased after VEGF overexpression, and this reduction could be reversed with VEGF receptor inhibitor treatment. In addition, after the different treatments, the cell migration rates of V-J cells were significantly increased compared with the control treatment. Taken together, these results indicate that sFlt-1 up-regulation by VEGF may be mediated by the VEGF/Flt-1 and/or VEGF/KDR signaling pathways. However, elucidating which pathway plays this key role requires further investigation.

Entities:  

Keywords:  Preeclampsia; Signaling pathways; VEGF-A; sFlt-1

Mesh:

Substances:

Year:  2018        PMID: 29497919     DOI: 10.1007/s11010-018-3337-5

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  29 in total

1.  Pravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse model.

Authors:  Keiichi Kumasawa; Masahito Ikawa; Hiroyasu Kidoya; Hidetoshi Hasuwa; Tomoko Saito-Fujita; Yuka Morioka; Nobuyuki Takakura; Tadashi Kimura; Masaru Okabe
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

2.  Circulating Angiogenic Factors and the Risk of Preeclampsia in Systemic Lupus Erythematosus Pregnancies.

Authors:  Alfredo Leaños-Miranda; Inova Campos-Galicia; María Guadalupe Berumen-Lechuga; Carlos José Molina-Pérez; Yolanda García-Paleta; Irma Isordia-Salas; Karla Leticia Ramírez-Valenzuela
Journal:  J Rheumatol       Date:  2015-05-15       Impact factor: 4.666

3.  Regulation of soluble Flt-1 (VEGFR-1) production by hnRNP D and protein arginine methylation.

Authors:  Takayuki Ikeda; Yasuo Yoshitomi; Hidehito Saito; Takeo Shimasaki; Hideki Yamaya; Takashi Kobata; Yasuhito Ishigaki; Naohisa Tomosugi; Yoshino Yoshitake; Hideto Yonekura
Journal:  Mol Cell Biochem       Date:  2016-01-04       Impact factor: 3.396

Review 4.  Maternal-fetal interactions, predictive markers for preeclampsia, and programming.

Authors:  Berthold Huppertz
Journal:  J Reprod Immunol       Date:  2014-12-04       Impact factor: 4.054

5.  Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome.

Authors:  Yan Zhou; Michael McMaster; Kirstin Woo; Mary Janatpour; Jean Perry; Terhi Karpanen; Kari Alitalo; Caroline Damsky; Susan J Fisher
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

6.  Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.

Authors:  Sharon E Maynard; Jiang-Yong Min; Jaime Merchan; Kee-Hak Lim; Jianyi Li; Susanta Mondal; Towia A Libermann; James P Morgan; Frank W Sellke; Isaac E Stillman; Franklin H Epstein; Vikas P Sukhatme; S Ananth Karumanchi
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

7.  Sodium nitrite attenuates hypertension-in-pregnancy and blunts increases in soluble fms-like tyrosine kinase-1 and in vascular endothelial growth factor.

Authors:  Victor Hugo Gonçalves-Rizzi; Jose Sergio Possomato-Vieira; Tamiris Uracs Sales Graça; Regina Aparecida Nascimento; Carlos A Dias-Junior
Journal:  Nitric Oxide       Date:  2016-05-12       Impact factor: 4.427

8.  A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies.

Authors:  J W Meekins; R Pijnenborg; M Hanssens; I R McFadyen; A van Asshe
Journal:  Br J Obstet Gynaecol       Date:  1994-08

9.  Embryonic development is disrupted by modest increases in vascular endothelial growth factor gene expression.

Authors:  L Miquerol; B L Langille; A Nagy
Journal:  Development       Date:  2000-09       Impact factor: 6.868

10.  Reduction of circulating soluble Flt-1 alleviates preeclampsia-like symptoms in a mouse model.

Authors:  Astrid Bergmann; Shakil Ahmad; Melissa Cudmore; Achim D Gruber; Petra Wittschen; Werner Lindenmaier; Gerhard Christofori; Volkmar Gross; Andrey Ch da Costa Gonzalves; Hermann-Josef Gröne; Asif Ahmed; Herbert A Weich
Journal:  J Cell Mol Med       Date:  2009-06-16       Impact factor: 5.310

View more
  6 in total

1.  Effect of Different Concentrations of Leukemia Inhibitory Factor on Gene Expression of Vascular Endothelial Growth Factor-A in Trophoblast Tumor Cell Line.

Authors:  K Hodakaram Jahanbin; Mehri Ghafourian; Mohammad Rashno
Journal:  Int J Fertil Steril       Date:  2020-07-15

2.  Serum concentration of matrix metalloproteinases and angiogenic factors in patients with venous leg ulcers.

Authors:  Paweł Kolano; Igor A Bednarski; Marzena Kraska-Gacka; Joanna Narbutt; Aleksandra Lesiak
Journal:  Postepy Dermatol Alergol       Date:  2021-05-22       Impact factor: 1.837

Review 3.  Pathogenesis of Preeclampsia and Therapeutic Approaches Targeting the Placenta.

Authors:  Manoj Kumar Jena; Neeta Raj Sharma; Matthew Petitt; Devika Maulik; Nihar Ranjan Nayak
Journal:  Biomolecules       Date:  2020-06-24

4.  Assessment of the SFlt-1 and sFlt-1/25(OH)D Ratio as a Diagnostic Tool in Gestational Hypertension (GH), Preeclampsia (PE), and Gestational Diabetes Mellitus (GDM).

Authors:  Malgorzata Walentowicz-Sadlecka; Piotr Domaracki; Pawel Sadlecki; Joanna Siodmiak; Marek Grabiec; Pawel Walentowicz; Maria Teresa Arias Moliz; Grazyna Odrowaz-Sypniewska
Journal:  Dis Markers       Date:  2019-08-06       Impact factor: 3.434

5.  Increased Angiogenesis and Lymphangiogenesis in the Placental Villi of Women with Chronic Venous Disease during Pregnancy.

Authors:  Miguel A Ortega; Miguel A Saez; Oscar Fraile-Martínez; Ángel Asúnsolo; Leonel Pekarek; Coral Bravo; Santiago Coca; Felipe Sainz; Melchor Álvarez- Mon; Julia Buján; Natalio García-Honduvilla
Journal:  Int J Mol Sci       Date:  2020-04-03       Impact factor: 5.923

6.  Placental trophoblast-specific overexpression of chemerin induces preeclampsia-like symptoms.

Authors:  Lunbo Tan; Zhilong Chen; Fen Sun; Zhuoqun Zhou; Baozhen Zhang; Baobei Wang; Jie Chen; Mengxia Li; Tianxia Xiao; Rugina I Neuman; Jianmin Niu; Koen Verdonk; Xifeng Lu; Jian V Zhang; A H Jan Danser; Qing Yang; Xiujun Fan
Journal:  Clin Sci (Lond)       Date:  2022-02-25       Impact factor: 6.124

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.